Benoit CANOLLE
CEO
At Skinosive, we believe that science should transform the way we protect our skin from UV rays, which cause skin cancer.
Thanks to our exclusive bio-adhesion technology, we are paving the way for a new generation of long-lasting sunscreens that are safer, more effective, and more sustainable.
This is just the beginning: our ambition is to go beyond sun protection and apply our technology to other beauty products, redefining the standards of dermo-cosmetics.
Our Vision
Skinosive is a science-based biotechnology company specializing in dermocosmetics, founded by Truffle Capital, which is developing a proprietary technology platform called “bioadhesion.”
Skin cancer is the leading cause of cancer among Caucasians. The best means of prevention remains sun protection, but this has two major limitations: its effectiveness, as it must be reapplied every two hours, and the issue of skin penetration.
Skinosive is the only company developing an innovation based on a new generation of safe, long-acting bioadhesive filters. This breakthrough represents a radical innovation in sun protection and skin cancer prevention.
The company is based in France, with headquarters in Paris and laboratories in Marseille
Our Mission
Revolutionizing sun protection through a unique biotechnology platform
Sticks to the skin
No need to reapply every 2 hours
Extended duration of effectiveness up to 8 hours
Does not penetrate the skin
